Academic literature on the topic 'Sarcomagenesis'

Create a spot-on reference in APA, MLA, Chicago, Harvard, and other styles

Select a source type:

Consult the lists of relevant articles, books, theses, conference reports, and other scholarly sources on the topic 'Sarcomagenesis.'

Next to every source in the list of references, there is an 'Add to bibliography' button. Press on it, and we will generate automatically the bibliographic reference to the chosen work in the citation style you need: APA, MLA, Harvard, Chicago, Vancouver, etc.

You can also download the full text of the academic publication as pdf and read online its abstract whenever available in the metadata.

Journal articles on the topic "Sarcomagenesis"

1

Cardona, Andrés Felipe, Jairo Zuluaga, Hernán Carranza, Jorge Miguel Otero, and Carlos Vargas. "Sarcomagenesis." Revista Colombiana de Hematología y Oncología 1, no. 4 (2012): 30–38. http://dx.doi.org/10.51643/22562915.321.

Full text
Abstract:
Los sarcomas representan un número heterogéneo de neoplasias que surgen de la transformación de algunas células mesenquimales primitivas. La evidencia ha aumentado de forma considerable respecto de las células pluripotenciales que dan origen a estos tumores y que parecen ser responsables de la iniciación, el mantenimiento, la diferenciación y la proliferación del osteosarcoma, sarcoma sinovial, rabdomiosarcoma y del sarcoma de Ewing. Se han adoptado diferentes métodos para la identificación de células primitivas en los sarcomas, tales como el uso de marcadores de superficie, la citometría de f
APA, Harvard, Vancouver, ISO, and other styles
2

Matushansky, Igor, and Robert G. Maki. "Mechanisms of Sarcomagenesis." Hematology/Oncology Clinics of North America 19, no. 3 (2005): 427–49. http://dx.doi.org/10.1016/j.hoc.2005.03.006.

Full text
APA, Harvard, Vancouver, ISO, and other styles
3

Hayashi, Takuma. "Genomic Analysis of Sarcomagenesis." Journal of Gynecology and Obstetrics Bulletin 1, no. 1 (2016): 1–2. http://dx.doi.org/10.24218/jgob.2016.01.

Full text
APA, Harvard, Vancouver, ISO, and other styles
4

Underhill, T. Michael. "Abstract IA004: Mesenchymal progenitors and sarcomagenesis." Clinical Cancer Research 28, no. 18_Supplement (2022): IA004. http://dx.doi.org/10.1158/1557-3265.sarcomas22-ia004.

Full text
Abstract:
Abstract Synovial sarcoma (SS) is an aggressive soft-tissue malignancy that can arise in any area of the body, and most frequently affects adolescents and young adults. The 10-year survival rate has been estimated at 50%. SS is characterized by a pathognomonic t(X;18)(p11.2;q11.2) translocation which produces a fusion oncogene named SS18-SSX. In mouse models, expression of SS18-SSX is sufficient to drive the development of SS-like tumors. Despite recent advancements in our understanding of SS biology, the cell of origin remains undefined. In most instances, it is likely mesenchymal in nature.
APA, Harvard, Vancouver, ISO, and other styles
5

Alba-Castellón, Lorena, Raquel Batlle, Clara Francí, et al. "Snail1 Expression Is Required for Sarcomagenesis." Neoplasia 16, no. 5 (2014): 413–21. http://dx.doi.org/10.1016/j.neo.2014.05.002.

Full text
APA, Harvard, Vancouver, ISO, and other styles
6

Esperança-Martins, Miguel, Iola F.Duarte, Mara Rodrigues, et al. "On the Relevance of Soft Tissue Sarcomas Metabolic Landscape Mapping." International Journal of Molecular Sciences 23, no. 19 (2022): 11430. http://dx.doi.org/10.3390/ijms231911430.

Full text
Abstract:
Soft tissue sarcomas (STS) prognosis is disappointing, with current treatment strategies being based on a “fit for all” principle and not taking distinct sarcoma subtypes specificities and genetic/metabolic differences into consideration. The paucity of precision therapies in STS reflects the shortage of studies that seek to decipher the sarcomagenesis mechanisms. There is an urge to improve STS diagnosis precision, refine STS classification criteria, and increase the capability of identifying STS prognostic biomarkers. Single-omics and multi-omics studies may play a key role on decodifying sa
APA, Harvard, Vancouver, ISO, and other styles
7

Rodriguez, Rene, Ruth Rubio, and Pablo Menendez. "Modeling sarcomagenesis using multipotent mesenchymal stem cells." Cell Research 22, no. 1 (2011): 62–77. http://dx.doi.org/10.1038/cr.2011.157.

Full text
APA, Harvard, Vancouver, ISO, and other styles
8

Radons, Jürgen. "Inflammatory stress and sarcomagenesis: a vicious interplay." Cell Stress and Chaperones 19, no. 1 (2013): 1–13. http://dx.doi.org/10.1007/s12192-013-0449-4.

Full text
APA, Harvard, Vancouver, ISO, and other styles
9

Miller, Henry E., Aparna Gorthi, Nicklas Bassani, Liesl A. Lawrence, Brian S. Iskra, and Alexander J. R. Bishop. "Reconstruction of Ewing Sarcoma Developmental Context from Mass-Scale Transcriptomics Reveals Characteristics of EWSR1-FLI1 Permissibility." Cancers 12, no. 4 (2020): 948. http://dx.doi.org/10.3390/cancers12040948.

Full text
Abstract:
Ewing sarcoma is an aggressive pediatric cancer of enigmatic cellular origins typically resulting from a single translocation event t (11; 22) (q24; q12). The resulting fusion gene, EWSR1-FLI1, is toxic or unstable in most primary tissues. Consequently, attempts to model Ewing sarcomagenesis have proven unsuccessful thus far, highlighting the need to identify the cellular features which permit stable EWSR1-FLI1 expression. By re-analyzing publicly available RNA-Sequencing data with manifold learning techniques, we uncovered a group of Ewing-like tissues belonging to a developmental trajectory
APA, Harvard, Vancouver, ISO, and other styles
10

Kannan, Sarmishta, Ian Lock, Benjamin B. Ozenberger, and Kevin B. Jones. "Genetic drivers and cells of origin in sarcomagenesis." Journal of Pathology 254, no. 4 (2021): 474–93. http://dx.doi.org/10.1002/path.5617.

Full text
APA, Harvard, Vancouver, ISO, and other styles
More sources

Dissertations / Theses on the topic "Sarcomagenesis"

1

Hall, Sarah Lynne. "Characterizing the contribution of hippo pathway dysregulation to sarcomagenesis." Thesis, University of Iowa, 2017. https://ir.uiowa.edu/etd/5769.

Full text
Abstract:
Sarcomas are cancers of mesenchymal origin. Though they comprise 15-20% of childhood cancers, and have a 5-year survival rate of 16% for metastatic disease, few targeted therapies exist, and the underlying mechanisms of their development are poorly understood. Transcriptional coactivators TAZ and YAP promote cell growth and proliferation, and are constitutively activated in a number of carcinomas. Accompanying TAZ/YAP activation in these cancers is decreased expression of Hippo pathway kinases MST1/2 and LATS1/2. As the Hippo pathway is the primary negative regulator of TAZ/YAP, this provides
APA, Harvard, Vancouver, ISO, and other styles
2

Siddiqi, Sara. "The Role of Hiwi in Stem Cell Maintenance and Sarcomagenesis." Thesis, 2012. https://doi.org/10.7916/D8K64R57.

Full text
Abstract:
Sarcomas are cancers of connective tissues, such as bone, adipose and cartilage, and are thought to arise from the aberrant development of the mesenchyme. As such, mesenchymal stem cells are thought to be the cell of origin for sarcomas. Genetic or epigenetic lesions at particular points during the differentiation of a mesenchymal stem cell into its terminal mesenchymal cell type are able to give rise to specific subtypes of sarcomas. Recently, a number of reports have identified elevated expression of the human Piwi homolog--called Hiwi--in a variety of human cancers, including gastric cance
APA, Harvard, Vancouver, ISO, and other styles
3

Hsueh, Cheng-Shun, та 薛丞舜. "Investigation of the Role of Nuclear Factor-kappa B (NF-κB) on Sarcomagenesis of Feline Injection Site Sarcoma". Thesis, 2019. http://ndltd.ncl.edu.tw/handle/m6zc3w.

Full text
Abstract:
碩士<br>國立臺灣大學<br>分子暨比較病理生物學研究所<br>107<br>Feline injection site sarcomas (FISSs) are malignant entities of mesenchymal origin. The disease has been proven to be associated with a vaccine adjuvant, aluminum, which serves as a stimulus, continuously inducing exaggerated inflammatory and immunologic reactions. Chronic inflammation has been implicated in sarcomagenesis. Among various factors, the activation of the nuclear factor-kappa B (NF-κB) signaling pathway has been documented to promote genes associated with tumor progression, and to up-regulate the expression of tumor-promoting cytokines and
APA, Harvard, Vancouver, ISO, and other styles

Books on the topic "Sarcomagenesis"

1

Siddiqi, Sara. The Role of Hiwi in Stem Cell Maintenance and Sarcomagenesis. [publisher not identified], 2012.

Find full text
APA, Harvard, Vancouver, ISO, and other styles

Book chapters on the topic "Sarcomagenesis"

1

Cardona, Andrés Felipe, Jairo Zuluaga, Hernán Carranza, Jorge Miguel Otero, Carlos Vargas, and León Darío Ortiz. "Sarcomagenesis." In Stem Cells in Cancer: Should We Believe or Not? Springer Netherlands, 2014. http://dx.doi.org/10.1007/978-94-017-8754-3_12.

Full text
APA, Harvard, Vancouver, ISO, and other styles
2

Cortner, J., G. F. Vande Woude, and S. Rong. "The Met-HGF/SF autocrine signaling mechanism is involved in sarcomagenesis." In Experientia Supplementum. Birkhäuser Basel, 1995. http://dx.doi.org/10.1007/978-3-0348-9070-0_6.

Full text
APA, Harvard, Vancouver, ISO, and other styles

Conference papers on the topic "Sarcomagenesis"

1

Jones, Kevin B. "Abstract IA20: Autophagy in alveolar soft part sarcomagenesis." In Abstracts: Advances in Sarcomas: From Basic Science to Clinical Translation; May 16-19, 2017; Philadelphia, PA. American Association for Cancer Research, 2018. http://dx.doi.org/10.1158/1557-3265.sarcomas17-ia20.

Full text
APA, Harvard, Vancouver, ISO, and other styles
2

Mater, David Van, Leonor Ano, Jordan Blum, and David G. Kirsch. "Abstract A64: A role for injury in sarcomagenesis." In Abstracts: AACR Special Conference: Pediatric Cancer at the Crossroads: Translating Discovery into Improved Outcomes; November 3-6, 2013; San Diego, CA. American Association for Cancer Research, 2014. http://dx.doi.org/10.1158/1538-7445.pedcan-a64.

Full text
APA, Harvard, Vancouver, ISO, and other styles
3

Ye, Shuai, Koreana Pak, Jennifer Shah, et al. "Abstract 3342: Hippo signaling promotes sarcomagenesis through the NF-kB pathway." In Proceedings: AACR Annual Meeting 2017; April 1-5, 2017; Washington, DC. American Association for Cancer Research, 2017. http://dx.doi.org/10.1158/1538-7445.am2017-3342.

Full text
APA, Harvard, Vancouver, ISO, and other styles
4

Jones, Kevin B., Benjamin Illum, Huifeng Jin, et al. "Abstract C12: Beta-catenin enhances synovial sarcomagenesis and provides a therapeutic target." In Abstracts: AACR-NCI-EORTC International Conference: Molecular Targets and Cancer Therapeutics--Oct 19-23, 2013; Boston, MA. American Association for Cancer Research, 2013. http://dx.doi.org/10.1158/1535-7163.targ-13-c12.

Full text
APA, Harvard, Vancouver, ISO, and other styles
5

Ye, Shuai, Koreana Pak, Jennifer Shah, et al. "Abstract B07: Regaining epigenetic control of the Hippo pathway to inhibit sarcomagenesis." In Abstracts: Advances in Sarcomas: From Basic Science to Clinical Translation; May 16-19, 2017; Philadelphia, PA. American Association for Cancer Research, 2018. http://dx.doi.org/10.1158/1557-3265.sarcomas17-b07.

Full text
APA, Harvard, Vancouver, ISO, and other styles
6

Lu, Chao, Siddhant Jain, Dominik Hoelper, et al. "Abstract PR12: Histone H3K36 mutations promote sarcomagenesis through altered histone methylation landscape." In Abstracts: Advances in Sarcomas: From Basic Science to Clinical Translation; May 16-19, 2017; Philadelphia, PA. American Association for Cancer Research, 2018. http://dx.doi.org/10.1158/1557-3265.sarcomas17-pr12.

Full text
APA, Harvard, Vancouver, ISO, and other styles
7

Eisinger, T. S. Karin. "Abstract IA12: Epigenetic deregulation of the Hippo pathway mediates NF-κB driven sarcomagenesis". У Abstracts: Advances in Sarcomas: From Basic Science to Clinical Translation; May 16-19, 2017; Philadelphia, PA. American Association for Cancer Research, 2018. http://dx.doi.org/10.1158/1557-3265.sarcomas17-ia12.

Full text
APA, Harvard, Vancouver, ISO, and other styles
8

Singer, Samuel. "Abstract IA18: Integrin-α10 drives metastasis and sarcomagenesis in mxyofibrosarcoma and undifferentiated pleomorphic sarcoma". У Abstracts: Advances in Sarcomas: From Basic Science to Clinical Translation; May 16-19, 2017; Philadelphia, PA. American Association for Cancer Research, 2018. http://dx.doi.org/10.1158/1557-3265.sarcomas17-ia18.

Full text
APA, Harvard, Vancouver, ISO, and other styles
9

Kendall, Genevieve C., Sarah Watson, Lin Xu, et al. "Abstract 872: Genetic models reveal that the novelVGLL2-NCOA2fusion oncogene leverages embryonic programs for sarcomagenesis." In Proceedings: AACR Annual Meeting 2019; March 29-April 3, 2019; Atlanta, GA. American Association for Cancer Research, 2019. http://dx.doi.org/10.1158/1538-7445.sabcs18-872.

Full text
APA, Harvard, Vancouver, ISO, and other styles
10

Kendall, Genevieve C., Sarah Watson, Lin Xu, et al. "Abstract 872: Genetic models reveal that the novelVGLL2-NCOA2fusion oncogene leverages embryonic programs for sarcomagenesis." In Proceedings: AACR Annual Meeting 2019; March 29-April 3, 2019; Atlanta, GA. American Association for Cancer Research, 2019. http://dx.doi.org/10.1158/1538-7445.am2019-872.

Full text
APA, Harvard, Vancouver, ISO, and other styles
We offer discounts on all premium plans for authors whose works are included in thematic literature selections. Contact us to get a unique promo code!